Bruker (NASDAQ:BRKR) Posts Earnings Results

Bruker (NASDAQ:BRKRGet Rating) released its quarterly earnings results on Wednesday. The medical research company reported $0.45 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.45, Fidelity Earnings reports. Bruker had a return on equity of 31.36% and a net margin of 11.06%. During the same quarter in the prior year, the company posted $0.44 earnings per share. Bruker updated its FY 2022 guidance to $2.29-$2.33 EPS and its FY22 guidance to $2.29-2.33 EPS.

Bruker Price Performance

Shares of BRKR traded down $0.96 during mid-day trading on Friday, hitting $62.48. 705,444 shares of the stock were exchanged, compared to its average volume of 666,700. The company has a market cap of $9.33 billion, a PE ratio of 34.52, a price-to-earnings-growth ratio of 1.69 and a beta of 1.17. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.72 and a current ratio of 2.55. The firm has a 50-day moving average of $63.54 and a two-hundred day moving average of $64.09. Bruker has a 52-week low of $55.80 and a 52-week high of $92.35.

Bruker Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 17th. Stockholders of record on Wednesday, June 1st were issued a dividend of $0.05 per share. The ex-dividend date was Tuesday, May 31st. This represents a $0.20 annualized dividend and a dividend yield of 0.32%. Bruker’s dividend payout ratio (DPR) is 11.05%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on BRKR shares. The Goldman Sachs Group cut their price target on Bruker from $73.00 to $60.00 and set a “sell” rating for the company in a research note on Wednesday, April 13th. StockNews.com cut Bruker from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 16th.

Hedge Funds Weigh In On Bruker

Several large investors have recently modified their holdings of the stock. The Manufacturers Life Insurance Company increased its position in shares of Bruker by 59.2% during the 1st quarter. The Manufacturers Life Insurance Company now owns 184,027 shares of the medical research company’s stock valued at $12,160,000 after purchasing an additional 68,411 shares during the last quarter. BNP Paribas Arbitrage SA grew its position in Bruker by 64.1% in the 1st quarter. BNP Paribas Arbitrage SA now owns 89,095 shares of the medical research company’s stock valued at $5,729,000 after acquiring an additional 34,801 shares during the last quarter. KB Financial Partners LLC grew its position in Bruker by 19.9% in the 1st quarter. KB Financial Partners LLC now owns 3,800 shares of the medical research company’s stock valued at $244,000 after acquiring an additional 630 shares during the last quarter. Point72 Hong Kong Ltd bought a new position in Bruker in the 1st quarter valued at $107,000. Finally, Quantamental Technologies LLC bought a new position in Bruker in the 1st quarter valued at $436,000. Institutional investors own 76.09% of the company’s stock.

About Bruker

(Get Rating)

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies.

Read More

Earnings History for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.